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Abstract: Sperm-associated antigen 6 (SPAG6) is the mammalian orthologue of Chlamydomonas PF16,
an axonemal central pair protein involved in flagellar motility. In mice, two Spag6 genes have been
identified. The ancestral gene, on mouse chromosome 2, is named Spag6. A related gene originally
called Spag6, localized on mouse chromosome 16, evolved from the ancient Spag6 gene. It has been
renamed Spag6-like (Spag6l). Spag6 encodes a 1.6 kb transcript consisting of 11 exons, while Spag6l
encodes a 2.4 kb transcript which contains an additional non-coding exon in the 30 -end as well as
the 11 exons found in Spag6. The two Spag6 genes share high similarities in their nucleotide and
amino acid sequences. Unlike Spag6l mRNA, which is widely expressed, Spag6 mRNA expression is
limited to a smaller number of tissues, including the testis and brain. In transfected mammalian cells,
SPAG6/GFP is localized on microtubules, a similar localization as SPAG6L. A global Spag6l knockout
mouse model was generated previously. In addition to a role in modulating the ciliary beat, SPAG6L
has many unexpected functions, including roles in the regulation of ciliogenesis/spermatogenesis,
hearing, and the immunological synapse, among others. To investigate the role of the ancient Spag6
gene, we phenotyped global Spag6 knockout mice. All homozygous mutant mice were grossly
normal, and fertility was not affected in both males and females. The homozygous males had
normal sperm parameters, including sperm number, motility, and morphology. Examination of testis
histology revealed normal spermatogenesis. Testicular protein expression levels of selected SPAG6L
binding partners, including SPAG16L, were not changed in the Spag6 knockout mice, even though
the SPAG16L level was significantly reduced in the Spag6l knockout mice. Structural analysis of
the two SPAG6 proteins shows that both adopt very similar folds, with differences in a few amino
acids, many of which are solvent-exposed. These differences endow the two proteins with different
functional characteristics, even though both have eight armadillo repeats that mediate protein–protein
interaction. Our studies suggest that SPAG6 and SPAG6L have different functions in vivo, with the
evolved SPAG6L protein being more important. Since the two proteins have some overlapping
binding partners, SPAG6 could have functions that are yet to be identified.

creativecommons.org/licenses/by/
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1. Introduction
Chlamydomonas PF16 encodes a protein localized in the central pair of the axoneme that
modulates flagellar motility [1]. Its mammalian orthologue, sperm-associated antigen 6
(Spag6), was first cloned by screening a human cDNA library using serum from an infertile
man who had a high titer of anti-sperm antibodies in his blood [2]. The mouse Spag6 gene
was subsequently cloned by screening a mouse testis cDNA library using a probe that
was generated by a polymerase chain reaction from a mouse EST clone that had a high
homology to human SPAG6 [3]. The mouse Spag6 gene was mapped to chromosome 16
using the T31 radiation hybrid panel [3]. Human and mouse SPAG6 proteins are abundant
in sperm tails. In transfected mammalian cells, SPAG6 decorates the microtubule [3].
To study the function of the mammalian Spag6 gene, a global Spag6 knockout mouse
model was generated. The homozygous Spag6 mutant mice were significantly impaired,
with 50% of mutant mice exhibiting premature death attributed to the development of
hydrocephalus. In the male mice that survived to adulthood, infertility was a prominent
phenotype, arising from a poor sperm motility and defective flagellar organization [4]. In
addition to the modulation of cilia/sperm motility, other functions of the mouse Spag6
gene were subsequently discovered. In the absence of SPAG6, motile ciliogenesis, axoneme
orientation, and polarity were altered in the trachea and middle ear epithelial cells [5,6].
Mouse SPAG6 also regulates fibroblast cell growth, morphology, migration, and primary
ciliogenesis [7]. Immune synapse formation/function as well as spiral ganglion neuron
development were also affected in the absence of SPAG6 [8,9]. More recent studies demonstrated that mouse SPAG6 is required for hearing and spermatogenesis [10–13]. These
studies demonstrate that mouse SPAG6 has broader functions than cilia/flagella motility.
PF16/SPAG6 proteins have eight armadillo repeats that mediate protein–protein interaction [1]. With the aid of yeast two-hybrid screening, it was discovered that SPAG6
is associated with a number of binding partners with different functions [10]. Diverse
functions for SPAG6 have also been identified in other species, including fish, chickens, and
pigs [14–19]. In humans, mutations in the SPAG6 gene have been associated with severe
asthenoteratospermia, characterized by multiple flagellar malformations, resulting in sterility [20]. In addition, studies have shown that SPAG6 expression is significantly increased
in a number of cancers [21–28], which further supports the notion that mammalian SPAG6
performs other functions in addition to modulating cilia/flagella motility.
Recently, another mouse Spag6 gene was discovered. It was originally named Spag6like (Spag6l) or Spag6-BC061194 [29]. The Spag6l gene, localized on chromosome 2, is in fact
the parental gene of Spag6, and the Spag6 gene localized on chromosome 16 was derived
from a duplication of the parental gene during evolution as analyzed by a phylogenetic
tree analysis [29]. Therefore, the parental Spag6l gene was renamed Spag6, and the evolved
Spag6 gene is now named Spag6l.
In this study, we characterized the mouse Spag6 gene and phenotyped global Spag6
knockout (KO) mice. Although the two Spag6 genes share high similarities in their nucleotide and amino acid sequences, the few different amino acids alter their functions.
Surprisingly, mice lacking SPAG6 did not show any gross abnormalities. Hydrocephalus
was not discovered in any of the mice analyzed. All homozygous mutant mice examined
were fertile, and the males showed normal spermatogenesis and sperm parameters. Testicular expression levels of selected proteins that were down-regulated in Spag6l KO mice
were not changed in the Spag6 KO mice. This phenotype was totally different from that
of the Spag6l KO mice, indicating that the ancient mouse Spag6 gene may have lost key
functions during evolution. Conversely, the Spag6l gene may have acquired functions in
addition to modulating cilia/flagella motility during evolution. Even though SPAG6 does
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not bind some proteins that bind to SPAG6L, both SPAG6 proteins bind TAC1, indicating
that SPAG6 might have yet to be determined roles in vivo.
2. Materials and Methods
2.1. Ethics Statement
Guidelines of the Wayne State University Institutional Animal Care with the Program
Advisory Committee (Protocol number: 21-01-3080) were observed in execution of all
animal research.
2.2. Constructs for the Studies
The coding region of mouse Spag6 cDNA was amplified by RT-PCR using the following primers: forward 50 -GAATTCATGAGCCAGCGGCAGGTGCTGCAA-30 ; reverse
50 -GGATCCCGTTAATAAGAGGCTGATAGCTGTCG-30 . The PCR product was cloned into
the pCR2.1 TOPO-TA vector. Fidelity of the PCR product was verified through sequencing
and the cDNA was, subsequently, subcloned into EcoR1/BamHI sites of the pEGFP-N2 vector, pGBK-T7 vector, and pGAD-T7 vector. Mouse Ccdc103 cDNA was amplified in a similar
fashion using the following primers: forward 50 -GAATTCGCCATGGAGAAGAACGATGT
AATC-30 ; reverse 50 -GGATCCCATGGACTCCATACAGTTCTAGCAG-30 . Mouse Ccdc103
cDNA was later subcloned into EcoR1/BamHI sites of the pGAD-T7 vector.
2.3. Animals and Genotyping
One pair of homozygous Spag6 global knockout mice was purchased from The
Jackson Laboratory (Bar Harbor, ME, USA; Stock# 033958), and the pair was used to
generate homozygous mice for the study. Heterozygous mice obtained by breeding
the homozygous male to a wild-type female were used as controls for the study. Genomic DNA was isolated from the toes of 7-day-old mice for characterization of genotype. Genotype was determined by PCR using the primer sets listed below: mSpag6F:
50 -GCATTTTCAGCACAGTTTGA-30 ; mSpag6RWT: 50 -TGGGAACTGCCTGGGATATG-30 ;
mSpag6RMU: 50 -GGATTATAGGCATGTACCTTTGC-30 . The mSpag6F/mSpag6RWT pair
amplified a wild-type band, and the mSpag6F/mSpag6RMU pair amplified a mutant band.
2.4. Histological Examination of Testicular and Epididymal Tissues
Testes and epididymides of adult mice were collected and fixed in 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) at 4 ◦ C overnight. The tissues were embedded in paraffin, sectioned at 5 µm thickness, deparaffined, and stained with hematoxylin
and eosin, in accordance with standard procedures. Slides were examined using a BX51
Olympus microscope (Olympus Corp., Center Valley, PA, USA), and photographs were
taken with a ProgRes C14 camera (JENOPTIK Laser, Jena, Germany).
2.5. RT-PCR
TRIzol (Invitrogen, Waltham, MA, USA) was utilized for total RNA extraction from
mouse testes. cDNA was synthesized through reverse transcription using first-strand
cDNA SensiFASTTM cDNA Synthesis Kit (Meridian Bioscience, Cincinnati, OH). The cDNA
was used as a template for RT-PCR using the following specific primers: (1) forward 50 ATGAGCCAGCGGCAGGTGCTGCAA-30 ; (2) reverse 50 -CGTTAATAAGAGGCTGATA
GCTGT-30 ; (3) reverse 50 GAGGAGAGGAGTGTTTACCAACCGC-30 ; (4) forward 50 -GCGGT
TGGTAAACACTCTCCTC-30 . Mouse Gapdh was amplified as the positive control using the
following primers: m-Gapdh 452 forward 50 -TAACCTCAGATCAGGGCGGA-30 ; m-Gapdh
452 reverse 50 -TGTAGGCCAGGTGATGCAAG-3’; a 452 bp product was amplified in all
mice. To further confirm that the exon 4 was deleted in the Spag6 KO mice, the PCR
products amplified by P1/P2 primer pair from a KO mouse and a wild-type mouse were
sequenced using the P1 primer, and the sequence results were compared to the Spag6 cDNA
sequence from GenBank (NM_001001334).
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2.6. Western Blotting
Homogenization in radioimmunoprecipitation assay (RIPA) buffer was performed to
mechanically lyse mouse testicular samples or cultured cells. Collected lysates were denatured by incubation at 95 ◦ C for 10 min. The samples were, subsequently, loaded onto 12%
sodium dodecyl sulfate-polyacrylamide gels, separated electrophoretically and transferred
to polyvinylidene difluoride membranes (Millipore Sigma, Burlington, MA, USA). The
membranes were blocked with Tris-buffered saline solution containing 5% non-fat dry milk
and 0.05% TWEEN 20 for 1 h , followed by incubation with the indicated antibodies at 4 ◦ C
overnight. After washing in TBST, the blots were incubated with secondary antibodies
conjugated with horseradish peroxidase for 1 h at room temperature. Following further
washes, the proteins were detected with Super Signal chemiluminescent substrate (Thermo
Scientific, Waltham, MA, USA). Antibodies used were: anti-GFP (Invitrogen, Waltham,
MA, USA, 1:2000, Cat no: MA5-15256); anti-β-actin (Cell Signaling Technology, Danvers,
MA, USA, 1:2000, Cat no: 4967S); anti-SPAG16L (1:1000, generated by our own laboratory);
anti-COPS5 (Sigma-Aldrich, St. Louis, MO, USA, 1:2000, Cat no: J3020).
2.7. Cell Culture and Transient Transfection
COS-1 cells and Chinese hamster ovary (CHO) cells were cultured in DMEM (Invitrogen, Waltham, MA, USA) supplemented with 10% fetal bovine serum and 5% L-glutamine
at 37 ◦ C. Transfection was performed with Lipofectamine™2000 transfection reagent (Invitrogen, Waltham, MA, USA) in accordance with the company’s protocol. The cells were,
subsequently, processed for Western blotting and immunofluorescence analyses.
2.8. Immunofluorescence Staining of Cultured Mammalian Cells
CHO cells were cultured in chambered slides. After transfection, the cells were fixed
in 4% paraformaldehyde/PBS at room temperature for 30 min, then washed with PBS. The
cells were permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) at
37 ◦ C for 10 min and blocked with 10 % goat serum (in PBS) for 1 h. The cells were washed
with PBS again and incubated with the indicated antibody (anti-α-tubulin: Proteintech,
Rosemont, IL, USA, 1:300, Cat no: 11224-1-AP) at 4 ◦ C overnight. After washing with PBS,
the samples were incubated with Cy3-conjugated secondary antibody at room temperature
for 1 h. The slides were washed with PBS and mounted in VectaMount with DAPI (Vector
Labs., Burlingame, CA, USA) and sealed with nail polish. Images were taken by confocal
laser-scanning microscopy (Leica SD600, Leica Microsystems, Wetzlar, Germany) and
processed using Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA, USA).
2.9. Male Fertility Test
Two-month-old Spag6 KO and control mice were independently mated with twomonth-old wild-type mice for one month. The presence of vaginal plugs was noted to
validate the occurrence of mating, and pregnancy in females was recorded. The number
of pups delivered in each litter was noted the day after birth. Average litter sizes were
total number o f pups born
obtained using the following formula: number o f mating cages .
2.10. Sperm Parameters
After breeding analyses, carbon dioxide inhalation followed by cervical dislocation
were performed to euthanize the mice. Sperm were collected from the cauda epididymis in
37 ◦ C PBS solution. Sperm motility was observed using an inverted microscope (Nikon,
Tokyo, Japan) equipped with 10× objective. Movies were recorded at 15 frames/sec with a
SANYO (Osaka, Japan) color charge-coupled device, high-resolution camera (VCC-3972)
and Pinnacle Studio HD (version 14.0) software (Corel, Ottawa, ON, Canada). In total,
10 fields were analyzed per sperm sample. Individual spermatozoa were tracked using
Image J (National Institutes of Health, Bethesda, MD, USA) and the plug-in tool MTrackJ.
Sperm motility was calculated as curvilinear velocity (VCL), which is equivalent to the
curvilinear distance (DCL) traveled by each individual spermatozoon in 1 s (VCL = DCL/t).
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To quantify sperm number, fixation was first conducted by incubation of sperm with 4%
paraformaldehyde for 15 min at room temperature. Cells were counted using a hemocytometer chamber under a light microscope, and total sperm number was extrapolated
based on standard methods.
2.11. Direct Yeast Two-Hybrid Assay
SPAG6L/pGBK-T7, COPS5/pGAD-T7, and TAC-1/pGAD-T7 plasmids were constructed previously [10]. To conduct direct yeast two-hybrid assays, the yeast was transformed with the indicated plasmids using the Matchmaker™ Yeast Transformation System
2 (Clontech, Mountain View, CA, USA, Cat#: 630439). Two plasmids containing simian
virus (SV), 40 large T antigen in pGAD-T7, and p53 in pGBK-T7 were co-transformed into
AH109 yeast as a positive control.
2.12. Structural Analysis and Comparison
The structures of SPAG6 and SPAG6L were predicted using the AlphaFold2 algorithm [30] as implemented in ColabFold [31]. Five structures were generated for each
(without relaxing the coordinates) and the lowest rank was compared. Alignment of the
structures was performed using the McLachlan algorithm [32] as implemented in the program ProFit (Martin, A.C.R. and Porter, C.T., http://www.bioinf.org.uk/software/profit/.
Accessed on 10 December 2021). Structure figures were generated using PyMOL (The
PyMOL Molecular Graphics System, Version 2.0, Schrödinger, LLC, New York, NY, USA.).
3. Results
3.1. Spag6 Shares High Sequence Homology with Spag6l
Mouse sperm-associated antigen 6 (NCBI reference sequence: NM_001001334.2) is
1651 bp long and consists of 11 exons. Mouse sperm-associated antigen 6-like (NCBI reference sequence: NM_015773.2) is 2483 bp long and consists of 12 exons, the last of which
is a non-coding exon. A comparison of the coding regions of Spag6 and Spag6l revealed a
high sequence homology (Supplemental Figure S1). The main difference that distinguishes
the two genes lies within exon 11. Spag6 contains six additional nucleotides prior to the
stop codon that are absent from Spag6l. The non-coding regions of exon 1 and 12 in Spag6l
also contain additional nucleotides that are not present in Spag6 (Figure 1A, Supplemental
Figure S1). These differences in the nucleotide sequences allowed us to design primers to
amplify the two Spag6 cDNAs separately. The two proteins are also conserved. They share
93% identity in amino acid composition (Figure 1B).
3.2. Spag6 and Spag6l Have Different mRNA Distributions In Vivo
To compare the mRNA distributions of the two Spag6 genes, specific primers that
target Spag6s were synthesized and RT-PCR was conducted. Spag6l mRNA was detected in
all of the tissues examined (Figure 2A). However, Spag6 mRNA was only detected in brain
and the testis, which had the highest level of expression. No Spag6 mRNA was detected in
the spleen, kidneys, or lungs (Figure 2B).
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3.2. Spag6 and Spag6l Have Different mRNA Distributions In Vivo
To compare the mRNA distributions of the two Spag6 genes, specific primers that
target Spag6s were synthesized and RT-PCR was conducted. Spag6l mRNA was detected
in all of the tissues examined (Figure 2A). However, Spag6 mRNA was only detected in
brain and the testis, which had the highest level of expression. No Spag6 mRNA was detected in the spleen, kidneys, or lungs (Figure 2B).
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3.3. SPAG6 Protein Has a Similar Localization as SPAG6L in Transfected Mammalian Cells
To evaluate the localization of SPAG6 in transfected mammalian cells, the
SPAG6/pEGFP-N2 plasmid was constructed. To test SPAG6/GFP fusion protein expression, COS-1 cells were transfected with an empty pEGFP-N2 plasmid and the
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Figure 2. Spag6 and Spag6l have different mRNA distributions in vivo. Total RNA was extracted
from the indicated tissues, and RT-PCR was conducted using specific primer sets targeting Spag6
and Spag6l. (A) RT-PCR to examine Spag6l mRNA expression; (B) RT-PCR to examine Spag6 mRNA
expression. Expression of Gapdh was examined as a control. Notice that Spag6 mRNA was detected
in the testis and brain, but not in other tissues examined. However, Spag6l mRNA was detected in
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3.4. Mice Deficient in Spag6 Gene Expression Are Grossly Normal and Fertile
A mouse knockout model was generated by The Jackson Laboratory using the CRISPR/cas9
system to disrupt the Spag6 gene on chromosome 2. Exon 4 of the gene was targeted for
deletion (Figure 4A). To validate the mutation, RT-PCR was conducted using testicular
cDNA with different primer sets. Given that exon 4 was deleted in the Spag6 KO mice, a
1.4kb PCR product was amplified from the KO mice when primer set P1/P2 was used, while
a 1.6 kb full-length Spag6 cDNA was amplified from the wild-type mice (Figure 4B(a)).
Primer P3 is a reverse primer located in the deleted exon of the Spag6 gene as well as
in exon 4 of the Spag6l gene. When primer set P1/P3 was used, the 346 bp PCR products were not only amplified from the wild-type mice, but also from the Spag6 KO mice
(Figure 4B(b)). P4 is a forward primer localized in the deleted exon 4, and P2 is a reverse
primer in exon 11 only targeting Spag6, not Spag6l. When the primer set P4/P2 was used,
the 1.2 kb PCR product was only amplified from the wild-type mice, not from the Spag6
KO mice (Figure 4B(c)). To further confirm that exon 4 was deleted in the Spag6 KO mice,
the PCR products amplified by the P1/P2 primer set from a KO mouse and a wild-type
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as well as in exon 4 of the Spag6l gene. When primer set P1/P3 was used, the 346 bp PCR
products were not only amplified from the wild-type mice, but also from the Spag6 KO
mice (Figure 4B(b)). P4 is a forward primer localized in the deleted exon 4, and P2 is a
reverse primer in exon 11 only targeting Spag6, not Spag6l. When the primer set P4/P2
was used, the 1.2 kb PCR product was only amplified from the wild-type mice, not 8from
of 15
the Spag6 KO mice (Figure 4B(c)). To further confirm that exon 4 was deleted in the Spag6
KO mice, the PCR products amplified by the P1/P2 primer set from a KO mouse and a
wild-type mouse were sequenced using the P1 primer, and the sequence results were
mouse were sequenced using the P1 primer, and the sequence results were compared to
compared to the mouse Spag6 mRNA sequence in GenBank. The wild-type mouse had an
the mouse Spag6 mRNA sequence in GenBank. The wild-type mouse had an intact exon
intact exon 4 sequence (Supplemental Figure S3A); however, exon 4 was missing in the
4 sequence (Supplemental Figure S3A); however, exon 4 was missing in the KO mouse
KO mouse (Supplemental Figure S3B). An in vitro translation assay revealed that an
(Supplemental Figure S3B). An in vitro translation assay revealed that an early stop code
early stop code was created after exon 4 was deleted (Supplemental Figure S3C).
was created after exon 4 was deleted (Supplemental Figure S3C).
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All Spag6 KO mice were grossly normal (Supplemental Figure S4A), and there was
All Spag6 KO mice were grossly normal (Supplemental Figure S4A), and there was no
no significant difference in body weight between the heterozygous control and homosignificant difference in body weight between the heterozygous control and homozygous
zygous knockout mice (Supplemental Figure S4B). Hydrocephalus, which was observed
knockout mice (Supplemental Figure S4B). Hydrocephalus, which was observed in the Spag6l
in the Spag6l knockout mice [4], was not seen in any of the Spag6 KO mice (Supplemental
knockout mice [4], was not seen in any of the Spag6 KO mice (Supplemental Figure S3C). No
Figure S3C). No abnormal behavior was observed in any of the control and homozygous
abnormal behavior was observed in any of the control and homozygous mice analyzed
mice analyzed throughout the studies.
throughout the studies.
Fertility of the homozygous Spag6 mutant mice was examined. All female and male
Fertility of the homozygous Spag6 mutant mice was examined. All female and male
mice
mice examined
examined were
were fertile,
fertile, with
with aa comparable
comparable number
number of
of pups
pups delivered
delivered in
in each
each litter
litter
(Table
1).
(Table 1).
Table 1. Fertility and fecundity of the Spag6 KO mice. To test fertility, 8 weeks old males were bred
with wild-type fertile females for one month, and litter size was recorded for each mating. a Number
of fertile mice/total number of mice.
Spag6 Genotype

Male Fertility a

Litter Size

Female Fertility a

Litter Size

+/−
−/−

6/6
6/6

7.9 ± 0.5
7.6 ± 0.7

6/6
6/6

8.1 ± 0.6
7.4 ± 0.5

3.5. Spag6 KO Mice Have Normal Sperm Parameters
Epididymal sperm from the control and Spag6 KO mice were examined. Sperm from
the two genotypes appeared to exhibit normal morphology with hook-shaped heads and
smooth, elongated tails (Supplemental Figure S5, Figure 5A,B). Sperm numbers in the KO
mice were not significantly different from those in controls (Figure 5C). Sperm motility was
also examined. Sperm from both control and KO mice were mostly motile and exhibited
progressive forward movement (Supplementary movie, Figure 5D,E).
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Epididymal sperm from the control and Spag6 KO mice were examined. Sperm from
the two genotypes appeared to exhibit normal morphology with hook-shaped heads and
smooth, elongated tails (Supplemental Figure S5, Figure 5A,B). Sperm numbers in the KO
mice were not significantly different from those in controls (Figure 5C). Sperm motility
9 ofex15
was also examined. Sperm from both control and KO mice were mostly motile and
hibited progressive forward movement (Supplementary movie, Figure 5D,E).

Figure 5. Normal sperm parameters in Spag6 KO mice. (A) Representative images of epidydimal
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3.6. Spermatogenesis Is Not Affected in Spag6 KO Mice
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3.7. Testicular Expression of Selected SPAG6L-Binding Partners in the Spag6-Deficient Mice
We previously discovered that expression levels of some SPAG6L-binding partners
were dramatically reduced in the Spag6l KO mice [10]. We evaluated expression levels
of selected proteins in the Spag6 KO mice. SPAG16L was found to be dependent on the
expression of SPAG6L. The Western blot analysis revealed that there was no difference in
expression levels of SPAG16L and COPS5, another SPAG6L binding partner, between the
control and Spag6-deficient mice (Figure 7).
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with well-aligned heads and tails. Sloughed round spermatids were rarely observed
in
both homozygous and heterozygous mutant mice.

Figure 6. Normal spermatogenesis in the Spag6 KO mice. (A) Representative H&E staining of the
adult testis of a control (+/−) mouse and a Spag6-KO littermate. The Roman numerals represent the
various stages of the tubules. The control testis showed normal seminiferous tubules structure,
with normal spermiation and release of spermatozoa (white arrows). In Spag6-deficient testis, a
similar histology was observed. P: pachytene spermatocytes; R: round spermatids; E: elongating
spermatids; T: tail of sperm being released; (B) representative H&E staining of the adult cauda
epididymis of a control (+/−) mouse and a Spag6-KO littermate. Notice that the lumens were filled
with sperm in mice of both genotypes. The insets show high magnification of images.
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3.7. Testicular Expression of Selected SPAG6L-Binding Partners in the Spag6-Deficient Mice
We previously discovered that expression levels of some SPAG6L-binding partners
were dramatically reduced in the Spag6l KO mice [10]. We evaluated expression levels of
selected proteins in the Spag6 KO mice. SPAG16L was found to be dependent on the expression of SPAG6L. The Western blot analysis revealed that there was no difference in
expression levels of SPAG16L and COPS5, another SPAG6L binding partner, between the
control and Spag6-deficient mice (Figure 7).

Figure 7. Expression of selected protein partners of SPAG6L was not affected by SPAG6 deficiency.
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3.8. Structural Differences between SPAG6 and SPAG6L
The predicted structures of both SPAG6 and SPAG6L had nearly identical overall folds
(Figure 8A) consisting of eight armadillo repeats with an overall backbone (Cα) root mean
square deviation of 0.730 Å (residues 1-507). The amino acids that differed between the
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Western blot results; (B) relative levels of SPAG16L and COPS5 normalized to β-actin.
suggests possible binding sites that differentially interacted with target proteins.
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folds (Figure 8A) consisting of eight armadillo repeats with an overall backbone (Cα) root
mean square deviation of 0.730 Å (residues 1-507). The amino acids that differed between
the two proteins are shown as spheres and colored yellow (Figure 8B), which shows that
they were spread throughout the domain and largely solvent-exposed. A few of these
amino acid differences formed small clusters on the protein surface (circled in Figure 8B),
11 of 15
which suggests possible binding sites that differentially interacted with target proteins.

Figure 8. SPAG6 and SPAG6L have distinct protein conformations. (A) Ribbon diagrams of the
aligned SPAG6 (blue) and SPAG6L (green) predicted structure show nearly identical folds for the
Figure 8. SPAG6 and SPAG6L have distinct protein conformations. (A) Ribbon diagrams of the
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3.9. SPAG6 and SPAG6L Bind to Different Proteins
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partners of SPAG6L in a yeast two-hybrid screen [10]. We decided to select two of12the
proteins. Direct yeast two-hybrid assays revealed that both SPAG6 and SPAG6L bound to
SPAG6L binding partners, TAC1 and COPS5, and tested if SPAG6 also bound to these
TAC1 (Figure 9, left). However, COPS5 interacted with SPAG6L but not SPAG6 in yeast
two proteins. Direct yeast two-hybrid assays revealed that both SPAG6 and SPAG6L
(Figure 9, right).
bound to TAC1 (Figure 9, left). However, COPS5 interacted with SPAG6L but not SPAG6
in yeast (Figure 9, right).
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4. Discussion
Here, we compared two mouse Spag6 genes, the ancient Spag6 gene that is located
on chromosome 2, and the evolved one, Spag6l, which is located on chromosome 16. Even
though the two Spag6 genes shared high similarities in their nucleotide and amino acid
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4. Discussion
Here, we compared two mouse Spag6 genes, the ancient Spag6 gene that is located on
chromosome 2, and the evolved one, Spag6l, which is located on chromosome 16. Even
though the two Spag6 genes shared high similarities in their nucleotide and amino acid
sequences, they had different expression patterns in vivo. The ancient Spag6 gene was
expressed in a limited number of tissues, including the testis and brain. In contrast, the
Spag6l gene was active in all tissues examined, including tissues without motile cilia, such
as the spleen and kidneys. The expression of Spag6l in tissues without motile cilia suggests
that the evolved gene acquired additional functions during evolution, which was supported
by the unexpected phenotypes identified in the Spag6l KO mice, including hearing loss,
impaired spermatogenesis, and immunological synapse formation [5–11]. It should be
noted that humans only have one known SPAG6 gene, and it remains to be determined if
other species have multiple expressed Spag6-related genes.
Different expression patterns in vivo suggested that the two Spag6 genes have different
regulatory mechanisms. Even though the coding sequences were highly similar, Spag6l
had a longer 50 -UTR in exon 1. In addition to the 11 exons present in both Spag6 genes,
Spag6l had an additional non-translated exon 12. Gene regulation through UTRs is one
of the key mechanisms that governs gene expression [33]. Transcription factors/RNA
binding proteins might bind to these UTRs to regulate Spag6l expression. Thus, the unique
non-translated sequences in the Spag6l gene could contribute to its different expression
pattern compared to the Spag6 gene in vivo.
Given that the two SPAG6 proteins were highly similar in their amino acid sequences,
it is not surprising that they had a similar localization in transfected CHO cells. Both
proteins decorated a subset of microtubules. Our earlier studies suggested that acetylated
α-tubulin might account for the subset of microtubules (7). However, it is not clear if the
two proteins have the same subcellular localization in vivo. We generated an anti-SPAG6L
antibody in rabbits using purified full-length SPAG6L [3]. The antibody should have
cross-reacted with both SPAG6 proteins. Differences in some amino acids between the two
SPAG6 protein sequences raised the possibility of generating antibodies that recognize the
individual SPAG6 proteins. However, none of the six antibodies we created using synthetic
peptides were able to distinguish the two proteins. Thus, specific antibodies against the two
SPAG6 proteins are still needed to characterize the localization of the two SPAG6 proteins
in vivo.
Even though no specific antibody targeting SPAG6 is available, RT-PCR using specific
primers demonstrated that the Spag6 gene on chromosome 2 was specifically disrupted
in our knockout model, and that Spag6l was not affected. However, the phenotype of
the Spag6 KO mice was totally different from the Spag6l KO. The phenotypes reported in
the Spag6l KO mice, including hydrocephalus, impaired sperm motility, and abnormal
spermatogenesis were not discovered in the Spag6 KO mice. As an ancient gene, the
translated SPAG6 protein may only retain its ancient functions. However, in addition to
the ancient functions, SPAG6L protein appears to have acquired other functions during
evolution. Therefore, it is likely that SPAG6L compensates for the function of SPAG6 when
Spag6 is disrupted. Conversely, SPAG6 may only partially compensate for the function of
SPAG6L when the Spag6l gene is disrupted. We expect that Spag6/Spag6l double KO mice
will have a more severely affected phenotype.
The different functions of the two SPAG6 proteins may be determined by the few
different amino acids between the two proteins, even though both SPAG6 proteins contain
armadillo repeats that mediate protein–protein interaction [34]. Given the high sequence
identity, the predicted overall fold of the two proteins was nearly identical. Of note, though,
a few of the amino acid differences appeared to form small clusters on the surface, which
may represent differential binding sites. One example was the interaction with COPS5.
The protein was identified to be a binding partner of SPAG6L [10]. However, SPAG6 did
not interact with COPS5 in our direct yeast two-hybrid assay. However, the two SPAG6
proteins both bound to TAC1. Thus, it appears that during evolution, due to changes in a
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few solvent-exposed amino acids, SPAG6L acquired the ability to interact with proteins
that do not bind to the ancient SPAG6, which may allow SPAG6L to perform new functions.
It will be interesting in the future to test if SPAG6 binds to other SPAG6L binding partners
identified in our previous study. Our Western blotting results examining selected SPAG6L
binding partners, including SPAG16L, did not support SPAG6 binding to the protein. A
yeast two-hybrid screen using SPAG6 as the bait may identify different binding partners
than those that interact with SPAG6L. However, given the phenotype of the Spag6 knockout
mice, the gene is probably less important than Spag6l in tissues with motile cilia.
A change in binding partner profiles during evolution is supported by another recent
study. In zebrafish, the SPAG6 protein, whose sequence is 80% identical to mouse SPAG6,
associates with Ccdc103, a coiled-coil domain-containing protein related to primary ciliary
dyskinesia [35]. However, in our direct yeast two-hybrid assay, neither SPAG6 nor SPAG6L
interacted with Ccdc103 (Supplemental Figure S8), suggesting that even though Ccdc103
and SPAG6 interact in zebrafish, they do not interact in mice. Thus, even though both
mouse SPAG6 proteins have conserved armadillo-repeat domains that mediate protein–
protein interaction, the few different amino acids might endow the two proteins with
common, but also some different binding partners, accounting for the overlap in binding
partners, but also differences.
In the present study, we only focused on the gross phenotype and reproduction of
the Spag6 KO mice. It remains to be determined if the ancient SPAG6 protein performed
other functions in vivo, particularly roles in polarity, cell growth, ciliogenesis, hearing and
immunologic functions as we identified in the Spag6l KO mice. Thus, further studies need
to be conducted to fully elucidate the function of the ancient Spag6 gene, including its
impact on CNS function. The two Spag6 mouse models provide tools to study the impact
of evolution on these related genes.
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